Measuring treatment response to advance precision medicine for multiple sclerosis
Abstract Objective To assess the independent contributions of clinical measures (relapses, Expanded Disability Status Scale [EDSS] scores, and neuroperformance measures) and nonclinical measures (new brain magnetic resonance imaging [MRI] activity and serum neurofilament light chain [sNfL] levels) f...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fa352fd8745148f48a725597ae0f7a77 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|